An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension

  1. Simon, M.A.
  2. Hanrott, K.
  3. Budd, D.C.
  4. Torres, F.
  5. Grünig, E.
  6. Escribano-Subias, P.
  7. Meseguer, M.L.
  8. Halank, M.
  9. Opitz, C.
  10. Hall, D.A.
  11. Hewens, D.
  12. Powley, W.M.
  13. Siederer, S.
  14. Bayliffe, A.
  15. Lazaar, A.L.
  16. Cahn, A.
  17. Rosenkranz, S.
Aldizkaria:
Pulmonary Circulation

ISSN: 2045-8940,  2045-8932

Argitalpen urtea: 2022

Alea: 12

Zenbakia: 1

Mota: Artikulua

DOI: 10.1002/PUL2.12024 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus